Verastem
Stacey Hill, MSN, ACNP-BC, currently serves as the Clinical Science Director at Verastem Oncology, leading Phase 1/2 programs for NSCLC G12C and PDAC. Prior experience includes serving as Associate Director of Clinical Research at Agenus, where contributions to Phase 2 trials and medical science liaison roles were essential in advancing immuno-oncology therapeutics. Earlier roles included Medical Science Liaison at Karyopharm Therapeutics, Key Account Manager and Territory Manager at Clovis Oncology, and Nurse Practitioner-GYN Oncology at Huntsville Hospital, where clinical research leadership and comprehensive patient care were provided. Stacey holds a Master’s degree in Nursing from the University of Alabama in Huntsville, complemented by a Bachelor’s degree in Nursing from the same institution.
This person is not in any teams
This person is not in any offices
Verastem
1 followers
Verastem Oncology (VSTM) is a biopharmaceutical company focused on development of medicines to improve the lives of patients diagnosed with cancer.